5-Chloropyridine-3-boronic acid → HCID 71059748, compound
Reaction equation
Br[C:2]1[CH:3]=[C:4]2[C@@:11]3([C:16]([F:18])([F:17])[CH2:15][O:14][C:13]([NH2:19])=[N:12]3)[CH2:10][C:9]([CH3:21])([CH3:20])[O:8][C:5]2=[CH:6][CH:7]=1.[Cl:22][C:23]1[CH:24]=[C:25](B(O)O)[CH:26]=[N:27][CH:28]=1>>[Cl:22][C:23]1[CH:24]=[C:25]([C:2]2[CH:3]=[C:4]3[C@@:11]4([C:16]([F:17])([F:18])[CH2:15][O:14][C:13]([NH2:19])=[N:12]4)[CH2:10][C:9]([CH3:21])([CH3:20])[O:8][C:5]3=[CH:6][CH:7]=2)[CH:26]=[N:27][CH:28]=1Participants
3
Procedure
In a manner analogous to that described in Example 19, the cross coupling reaction of (R)-6-bromo-5′,5′-difluoro-2,2-dimethyl-5′,6′-dihydrospiro[chroman-4,4′-[1,3]oxazin]-2′-amine (intermediate B6.5) with 5-chloropyridin-3-ylboronic acid yielded the title compound (78% yield) as a white powder. MS (ISP): m/z=394.1 [M+H]+.
Sources & evidence
- ORD record
- ord-89aa7175f0d6471c9613a015b8e2a4e8
- Source dataset
- uspto-grants-2015_07
- Patent number
- US09079919B2
Reaction notes
Loading…